1) Interesting findings of additional utility of Semaglutide(brand name Ozempic) in September issue of New England Journal of Medicine. Heart failure symptoms, exercise function much improved and greater weight loss after 52 weeks of weekly injections.

Neurosurgeon interested in blockchain applications for healthcare delivery efficiency and web3 for educational product dissemination.

2) This can lead to quality of life improvement. The study was of patients with heart failure but normal ejection fraction and bmi>30.